China MediaExpress Draws Interest - Some of It the Wrong Kind [View article]
Good article Glen, congratulations!
The biggest fraud is not China but a company called China Crescent Enterprises (CCTR) run by American crooks who run more OTC BB debt-to-equity schemes and the funny part is everyone knows it but nobody takes action. The SEC is so ignorant.
U.S. to Police OTCBB IPOs, Reverse Mergers for Chinese Stocks: It's About Time [View article]
Of course Mr. Fuhrman has also his own interests by posting this article. China First Capital wants also a piece of the cake.
The valuation issues (undervaluation compared to other markets) mentioned in the article will fade away if investor confidence comes back in the market and the broad public knows that not every OTC BB China stock is a fraud.
Good investor relations, a decent auditor and solid earnings are the key elements of getting back the confidence in the China RTO space. This will take some time but will occur if companies and markets mature.
U.S. to Police OTCBB IPOs, Reverse Mergers for Chinese Stocks: It's About Time [View article]
Peter, I partly agree with your article. Why, partly?
Not all the RTO's or IPO's on the OTC BB are frauds or have bad attentions towards investors.
I think the major U.S. Stock Exchanges have to build a platform for Chinese stocks with all the necessary regulations and requirements where only Chinese stocks can be traded. These stocks can than be categorized in 3 types of shares (C1, C2 and C3) all with their own requirements.
A name could be the China American Stock Exchange (CASE) for example. So Westerners can buy the shares at that exchange. The problem is that a lot of European and US private investors can't trade in China, Hong Kong or other South East Asian countries.
SkyPeople Fruit Juice: Sky High Stock Opportunity for Value Investors [View article]
I was looking for some Chinese stocks, but I guess OTC-stocks are not covered on "lampfair". Personally I like more the site Trading China www.fixyou.co.uk/
Chinese Reverse Mergers: Beware of Accounting Problems [View article]
The most important is the management of US-listed companies.
If management is serious about their corporate responsibilities and is fully cooperating with accounting firms this could be a sign that fraud is not eminent.
How to Profit From the Resurgence of ChinaHybrid Stocks [View article]
QUESTION: 3Qs are always the weakest, you mentioned in your 10Q. What are the Company’s plans to make the 3Q a consistent quarter in line with the other quarters?
ANSWER: We plan to introduce a new product, the Qing Re Jie Du Oral Liquid which with this we will be able to be as a successful product as we have achieved [unintelligible] in the 3Q, and we will continue also to [unintelligible] Siberian Ginseng to increase our sales of existing products.
Latin American Gold Juniors in Focus [View article]
Personally I think Impact Silver, Goldgroup Mining and Genco Resources have huge potential and are still modestly priced if you compare them with other juniors.
How to Profit From the Resurgence of ChinaHybrid Stocks [View article]
Good article Maj!!
As you know I am long Renhuang Pharmaceuticals (CBP) and I really think they some issues are resolved. In May they appointed PricewaterhouseCoopers to develop a SOX 404 compliance program.
"We are pleased to engage PwC's assistance in this important effort to ensure that Renhuang is in full compliance with the SOX 404 reporting requirements," said Mr. Shaoming Li, Chairman and Chief Executive Officer of Renhuang. Mr. Li added "Working with PwC, a leading global accounting firm, will further strengthen our internal controls, corporate governance and risk management procedures. We are committed to establishing and maintaining sound corporate governance principles, which is critical to creating long-term shareholder value. We hope that our efforts will increase shareholders' confidence in our financial reporting and internal controls standards."
We are already seeing the fruits of the program, the stock price is going up bit by bit. But from a valuation standpoint Renhuang is still deeply undervalued. Time will tell us, if we will see $ 5.00 on the boards.
China's Xinyuan Real Estate: An Undervalued Long Opportunity [View article]
www.nasdaq.com/asp/hol...
China's Xinyuan Real Estate: An Undervalued Long Opportunity [View article]
China MediaExpress Draws Interest - Some of It the Wrong Kind [View article]
The biggest fraud is not China but a company called China Crescent Enterprises (CCTR) run by American crooks who run more OTC BB debt-to-equity schemes and the funny part is everyone knows it but nobody takes action. The SEC is so ignorant.
U.S. to Police OTCBB IPOs, Reverse Mergers for Chinese Stocks: It's About Time [View article]
The valuation issues (undervaluation compared to other markets) mentioned in the article will fade away if investor confidence comes back in the market and the broad public knows that not every OTC BB China stock is a fraud.
Good investor relations, a decent auditor and solid earnings are the key elements of getting back the confidence in the China RTO space. This will take some time but will occur if companies and markets mature.
U.S. to Police OTCBB IPOs, Reverse Mergers for Chinese Stocks: It's About Time [View article]
Not all the RTO's or IPO's on the OTC BB are frauds or have bad attentions towards investors.
I think the major U.S. Stock Exchanges have to build a platform for Chinese stocks with all the necessary regulations and requirements where only Chinese stocks can be traded. These stocks can than be categorized in 3 types of shares (C1, C2 and C3) all with their own requirements.
A name could be the China American Stock Exchange (CASE) for example. So Westerners can buy the shares at that exchange. The problem is that a lot of European and US private investors can't trade in China, Hong Kong or other South East Asian countries.
SkyPeople Fruit Juice: Sky High Stock Opportunity for Value Investors [View article]
www.fixyou.co.uk/
New Energy Systems Group: Larger, But Still Undervalued [View article]
Dongsheng Increases Cardiovascular Focus With New Drug Acquisition [View article]
Chinese Reverse Mergers: Beware of Accounting Problems [View article]
If management is serious about their corporate responsibilities and is fully cooperating with accounting firms this could be a sign that fraud is not eminent.
Still Optimistic About China Intelligent Lighting [View article]
www.newscenter.philips...
From page 58 until page 70 you see more of their Light Division.
How to Profit From the Resurgence of ChinaHybrid Stocks [View article]
ANSWER: We plan to introduce a new product, the Qing Re Jie Du Oral Liquid which with this we will be able to be as a successful product as we have achieved [unintelligible] in the 3Q, and we will continue also to [unintelligible] Siberian Ginseng to increase our sales of existing products.
Q/A-session
chinainvestorking.blog...
Latin American Gold Juniors in Focus [View article]
seekingalpha.com/insta...
The only thing that worries me is the rising security costs of miners that have their operations in Mexico.
www.reuters.com/articl...
The miners mentioned in my article operate in more stable jurisdictional areas where security is more tight.
How to Profit From the Resurgence of ChinaHybrid Stocks [View article]
As you know I am long Renhuang Pharmaceuticals (CBP) and I really think they some issues are resolved. In May they appointed PricewaterhouseCoopers to develop a SOX 404 compliance program.
"We are pleased to engage PwC's assistance in this important effort to ensure that Renhuang is in full compliance with the SOX 404 reporting requirements," said Mr. Shaoming Li, Chairman and Chief Executive Officer of Renhuang. Mr. Li added "Working with PwC, a leading global accounting firm, will further strengthen our internal controls, corporate governance and risk management procedures. We are committed to establishing and maintaining sound corporate governance principles, which is critical to creating long-term shareholder value. We hope that our efforts will increase shareholders' confidence in our financial reporting and internal controls standards."
We are already seeing the fruits of the program, the stock price is going up bit by bit. But from a valuation standpoint Renhuang is still deeply undervalued. Time will tell us, if we will see $ 5.00 on the boards.
China New Borun: Born to Run or Destined to Fall? [View article]
China New Borun: Born to Run or Destined to Fall? [View article]
"It is impossible to go through life without trust:
That is to be imprisoned in the worst cell of all, oneself. "
Graham Greene